Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico – Thomas Kingsley Brown

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



http://psychedelicscience.org

Help us caption and translate this video on Amara.org:‪ ‬http://www.amara.org/en/videos/ypBoaytF37qb/info/

Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico

Thomas Kingsley Brown, PhD

This presentation is an overview of the MAPS-funded study of long-term outcomes for ibogaine-assisted treatment of opiate dependence for patients at two clinics in Baja California, Mexico. Beginning in September of 2010, the study enrolled thirty US residents seeking ibogaine treatment for opiate dependence at ...

Continue Reading →

Notes on Progress in the New Zealand Ibogaine Study – Geoff Noller

< !DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">



http://psychedelicscience.org

Help us caption and translate this video on Amara.org:‪ ‬http://www.amara.org/en/videos/w5HzSJBjBSdf/info/

Notes on Progress in the New Zealand Ibogaine Study

Geoff Noller, PhD

This presentation reports on the first year of progress in the New Zealand observational study of ibogaine treatment outcomes for opioid-dependent persons. Current participants’ data are reviewed and the implications of New Zealand’s ibogaine legislation for research and treatment are discussed.

Dr. Geoff Noller has a background in ...

Continue Reading →

Rick Doblin, Ph.D. Shares his Ibogaine Experience

Rick Doblin, Ph.D. Founder of psychedelic research group MAPS, talks about his experience with Ibogaine and LSD, in order to confront his own shadows and be more effective as a political activist.

Connect with Rick: http://www.maps.org | rick@maps.org

Also featuring Alan Steinfeld who assisted in the interviewing of Rick.
Connect with Alan: http://www.newrealities.com | newrealities@earthlink.net

source

Continue Reading →
Page 4 of 4 1234
SSL Certificates
UA-77446339-1